What factors influence the length of stay and readmission after deep brain stimulation surgery? a tertiary centre study

PURPOSE: Deep Brain Stimulation (DBS) is a well-established treatment for refractory movement disorders. However, there are surgical risks and it often includes in-patient hospital admission. The aim is to review key factors associated with prolonged length of stay (LoS)(defined here as > 2 nights), and readmission within six months. METHODS: We retrospectively reviewed medical records of patients who underwent DBS insertion between October 2016 and September 2024 in our tertiary centre. Patient and operative factors were reviewed. RESULTS: 397 DBS procedures(388 patients) were included. Parkinson's disease (PD) patients constitute majority(73%), followed by Essential Tremor(13%). Mean LoS were 2.39 ± 0.2 and 2.48 ± 0.5 nights, respectively. Within PD cohort, older age and use of blood thinners were associated with increased LoS. Other factors such as gender, baseline Unified Parkinson's Disease Rating Scale-3 score, symptom duration, and operating time were not statistically significant. Readmission rate was 10.3%(41/397), with majority secondary to infection(20/41) or planned readmission(13/41). Excluding planned readmissions, average LoS during readmission was 13.4 ± 0.6 nights, with majority readmitted > 30 days post-discharge (15/27). Within PD, readmission rate was 6.9%(19/276), with skull-mounted implant use identified as risk factor. CONCLUSIONS: This study identified risk factors for prolonged hospital stay after DBS surgeries, with our surgical workflow, in a publicly-funded healthcare system. We also captured factors associated with readmission within six months, which is a much longer timeframe than most studies in literature. This provides information to facilitate prehabilitation, resource allocation, and patient counselling to optimise patient outcome and reduce treatment costs. Further studies are warranted to confirm these findings, especially with different DBS techniques and workflows.

Authors

Institutions

Publication Details

Journal
Acta Neurochirurgica
Published
2026-04-15
DOI
https://doi.org/10.1007/s00701-026-06855-x
Primary Topic
Neurological disorders and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What factors influence the length of stay and readmission after deep brain stimulation surgery? a tertiary centre study

Reiko Ashida, Jason Yuen, Adam Williams, Emily Boyd et al.
Acta Neurochirurgica
Neurological disorders and treatments
article

What factors influence the length of stay and readmission after deep brain stimulation surgery? a tertiary centre study

Reiko Ashida, Jason Yuen, Adam Williams, Emily Boyd, Madelaine Miller
article en

Abstract

PURPOSE: Deep Brain Stimulation (DBS) is a well-established treatment for refractory movement disorders. However, there are surgical risks and it often includes in-patient hospital admission. The aim is to review key factors associated with prolonged length of stay (LoS)(defined here as > 2 nights), and readmission within six months. METHODS: We retrospectively reviewed medical records of patients who underwent DBS insertion between October 2016 and September 2024 in our tertiary centre. Patient and operative factors were reviewed. RESULTS: 397 DBS procedures(388 patients) were included. Parkinson's disease (PD) patients constitute majority(73%), followed by Essential Tremor(13%). Mean LoS were 2.39 ± 0.2 and 2.48 ± 0.5 nights, respectively. Within PD cohort, older age and use of blood thinners were associated with increased LoS. Other factors such as gender, baseline Unified Parkinson's Disease Rating Scale-3 score, symptom duration, and operating time were not statistically significant. Readmission rate was 10.3%(41/397), with majority secondary to infection(20/41) or planned readmission(13/41). Excluding planned readmissions, average LoS during readmission was 13.4 ± 0.6 nights, with majority readmitted > 30 days post-discharge (15/27). Within PD, readmission rate was 6.9%(19/276), with skull-mounted implant use identified as risk factor. CONCLUSIONS: This study identified risk factors for prolonged hospital stay after DBS surgeries, with our surgical workflow, in a publicly-funded healthcare system. We also captured factors associated with readmission within six months, which is a much longer timeframe than most studies in literature. This provides information to facilitate prehabilitation, resource allocation, and patient counselling to optimise patient outcome and reduce treatment costs. Further studies are warranted to confirm these findings, especially with different DBS techniques and workflows.

Acta Neurochirurgica
Southmead Hospital (GB), University of Bristol (GB)
Openalex Percentile: Top 13%
Neurological disorders and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.